Raphael Buzzi
The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Akeret K, Buzzi R, Saxenhofer M, Bieri K, Chiavi D, Thomson B, Grüttner-Durmaz M, Schwendinger N, Humar R, Regli L, van Doormaal T, Held U, Keller E, Hugelshofer M, Schaer D, Hostettler I. The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurol 2022; 22:267.
Jul 18, 2022The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Jul 18, 2022BMC Neurol 2022; 22:267
Akeret Kevin, Buzzi Raphael, Saxenhofer Moritz, Bieri Kathrin, Chiavi Deborah, Thomson Bart R, Grüttner-Durmaz Manuela, Schwendinger Nina, Humar Rok, Regli Luca, van Doormaal Tristan P C, Held Ulrike, Keller Emanuela, Hugelshofer Michael, Schaer Dominik J, Hostettler Isabel C
Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target.
Hugelshofer M, Sikorski C, Seule M, Deuel J, Muroi C, Seboek M, Akeret K, Buzzi R, Regli L, Schaer D, Keller E. Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target. World Neurosurg 2018; 120:e660-e666.
Aug 27, 2018Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target.
Aug 27, 2018World Neurosurg 2018; 120:e660-e666
Hugelshofer Michael, Sikorski Christopher M, Seule Martin, Deuel Jeremy, Muroi Carl I, Seboek Martina, Akeret Kevin, Buzzi Raphael, Regli Luca, Schaer Dominik J, Keller Emanuela